Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulphate in PIP and ESP Blocks for Post-Mastectomy Pain
NCT07438366Not yet recruiting
- Sponsor
- South Egypt Cancer Institute
- Start
- Feb 2026
- Primary completion
- Nov 2026
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of magnesium sulfate in Post-mastectomy pain syndrome (PMPS) (2 arms), sponsored by South Egypt Cancer Institute. Primary endpoint: Time to first rescue analgesia at 24 hours. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
Post-mastectomy pain syndrome (PMPS)
Beyond the preview
Go deeper on NCT07438366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07438366.